Anand P et al. Bioavailability of curcumin: problems and promises. Molecular Pharmaceutics 2007;4:807–818.
Lee SH et al., Piperine-mediated drug interactions and formulation strategy for piperine: recent advances and future perspectives, Expert Opin Drug Metab Toxicol 2018;14:43–57.
Halegoua-DeMarzio D et al., Liver injury associated with turmeric – a growing problem: ten cases from the Drug-Induced Liver Injury Network (DILIN), Am J Med 2023;136:200–206.
Shrestha A et al., Drug-induced liver injury associated with turmeric and piperine: a case and review, Case Rep Gastroenterol 2025;19:96–106.
Lee Y-M et al., Is curcumin intake really effective for chronic inflammatory metabolic disease? A review of meta-analyses of randomized controlled trials, Nutrients 2024;16:1728.
Shrestha A et al., Drug-induced liver injury associated with turmeric and piperine: a case and review, Case Rep Gastroenterol 2025;19:96–106.
National Institute of Diabetes and Digestive and Kidney Diseases, LiverTox: clinical and research information on drug-induced liver injury – Turmeric, Bethesda (MD) 2012–[updated 2025 Jun 16].
Suhasini G et al., A comprehensive review on hepatotoxicity associated with Curcuma longa (L.) consumption highlighting mechanisms, susceptibility factors, and clinical findings, J Dalian Univ Technol 2025;32:314–323.
Prasad S et al., Turmeric, the golden spice: from traditional medicine to modern medicine, in: Benzie IFF, Wachtel-Galor S, editors, Herbal Medicine: Biomolecular and Clinical Aspects, 2nd ed., Boca Raton (FL): CRC Press/Taylor & Francis; 2011, Chapter 13.
Singh P et al., Turmeric spice: authenticity, fraud detection, and traceability vis-à-vis consumer health, Food Nutr Chem 2025;3:235.
Toden S et al., The holy grail of curcumin and its efficacy in various diseases: is bioavailability truly a big concern?, J Restor Med 2017;6:27–36.
Anand P, Kunnumakkara AB, Newman RA, Aggarwal BB. Bioavailability of curcumin: problems and promises. Mol Pharm. 2007;4(6):807-818. doi:10.1021/mp700113r